Dalamycin (Vaginal Cream)

Antibiotic for Bacterial Vaginitis Treatment

Composition:
Each 1g Vaginal Cream contains 20mg Clindamycin Base.

Indications:
Dalamycin is an antibiotic agent, which has shown to be effective in the treatment of infection caused by susceptible anaerobic bacteria, or susceptible strains of gram positive aerobic bacteria. Dalamycin has been shown to have in-vitro activity against the following organisms, which are associated with bacterial vaginitis such as: Gardnerella vaginalis, mobilinas, bacteroides, mycoplasma hominis, peptostreptococcus.
Dalamycin Vaginal Cream is indicated for the treatment of bacterial vaginitis.

Usage:
Dosage of Dalamycin Vaginal Cream is inserted as deeply as possible into the vagina twice daily (in the morning and evening) for three consecutive days, or once daily for six consecutive days, preferably at night (See the instructions of the applicator usage).
(Each 5g applicator dosage contains approximately 100mg Clindamycin Base).
Treatment should be timed so as to avoid the menstrual period and be finished before the onset of menstruation.
The drug is not recommended for children and the elderly over 60 years.

Side Effect:
It may cause: Cervicitis, vulva vaginal irritation.

Contraindications:
Hypersensitivity to the drug.

Drug interaction:
It may cause cross-resistance with lincomycin or erythromycin. It may cause antagonism with erythromycin.

Use in Pregnancy or Lactation:
It could be used during the first trimester of pregnancy only if clearly needed. It can be used in the second trimester but we must weigh the benefit against the possible risk. Also it can be used during lactation but we should weigh the benefit against the possible risk.

Pharmacokinetic Properties:
Following once a day dosing of 100mg, the peak serum clindamycin level average is about 20 nanogram/ml. Approximately 3% of the administered dose is absorbed systematically.

Presentation:
Carton pack contains aluminum tube of 40g with vaginal applicator, and leaflet.

 

 

 
 
 

© 2010 Domina Pharmaceuticals